Interest expense increased $6.2 million, or 17.4%, during the year ended December 31, 2019, primarily as a result of the increase in overall debt outstanding, increased amortization of deferred financing cost as a result of the credit facility amendment, and higher interest rates, partially offset by increased capitalized interest due to development space under construction at BO1, CH2, LA3, NY2, SV8, and VA3. The weighted average principal debt outstanding was $1.3 billion and $1.0 billion during the years ended December 31, 2019, and 2018, respectively. Our daily weighted average interest rate increased from 3.58% during the year ended December 31, 2018, to 3.83% during the year ended December 31, 2019.
Liquidity and Capital Resources
Discussion of Cash Flows
Year Ended December 31, 2019, Compared to Year Ended December 31, 2018
Operating Activities
Net cash provided by operating activities was $251.6 million for the year ended December 31, 2019, compared to $258.8 million for the year ended December 31, 2018. This decrease of $7.2 million, or 2.8%, was primarily due to increased accounts receivable of $2.8 million during the year ended December 31, 2019, compared to a decrease of $10.9 million during the year ended December 31, 2018. In addition, other liabilities decreased by $7.8 million, primarily due to the settlement of an interest rate swap. The decrease was partially offset by organic growth of our customer revenue base through expansions into new and existing space and as our existing customers increased their power consumption within their deployments.
Investing Activities
Net cash used in investing activities increased by $116.6 million, or 45.6%, to $372.3 million for the year ended December 31, 2019, compared to $255.6 million for the year ended December 31, 2018. This increase was due primarily to higher construction spend on our BO1, CH2, LA3, NY2, SV8, and VA3 development properties and the acquisition of SV9 during the year ended December 31, 2019, compared to construction spending on fewer active development projects during the year ended December 31, 2018.
Financing Activities
Net provided by financing activities was $121.1 million during the year ended December 31, 2019, compared to net cash used in financing activities of $5.8 million during the year ended December 31, 2018.
During the year ended December 31, 2019, we received cash proceeds from issuance of the 2026 Notes, the 2029 Notes, and the 2025 Term Loan (each as defined below), for an aggregate of $500 million, and we made net cash payments on the revolving credit facility of $149.0 million.
During the year ended December 31, 2018, we received cash proceeds from the issuance of 2023 Term Loan, (as defined below), of $150.0 million, and we received cash proceeds, net of payments, from the revolving credit facility of $42.0 million.
We paid $223.9 million in dividends and distributions on our common stock and Operating Partnership units during the year ended December 31, 2019, compared to $193.0 million during the year ended December 31, 2018, as a result of an increase in the annual dividend from $4.02 per share and unit paid during the year ended December 31, 2018, to an annual dividend of $4.64 per share and unit paid during the year ended December 31, 2019.
Analysis of Liquidity and Capital Resources
We have an effective shelf registration statement that allows us to offer for sale various unspecified classes of equity and debt securities. As circumstances warrant, we may issue debt and/or equity securities from time to time on an opportunistic basis, dependent upon market conditions and available pricing. We make no assurance that we can issue and sell such securities on acceptable terms or at all.